Clevudine

ANTIINFECTIVES FOR SYSTEMIC USE

Key facts

Clevudine is a drug catalogued in DrugCentral. Recorded indications include Chronic type B viral hepatitis.

• Indications: Chronic type B viral hepatitis.
• ATC code: J05AF12 (Nucleoside and nucleotide reverse transcriptase inhibitors).
• Molecular formula: C10H13FN2O5; molecular weight 260.22 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Chronic type B viral hepatitis

ATC classification

ATC code	Therapeutic hierarchy
J05AF12	ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Nucleoside and nucleotide reverse transcriptase inhibitors

Chemical structure

• Molecular formula: C₁₀H₁₃FN₂O₅
• Molecular weight: 260.22 g/mol
• CAS number: 163252-36-6
• InChIKey: GBBJCSTXCAQSSJ-XQXXSGGOSA-N
• PubChem CID: 73115

CC1=CN([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)C(=O)NC1=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Clevudine used for?

DrugCentral lists the following indications for Clevudine: Chronic type B viral hepatitis.

What is the chemical formula of Clevudine?

Clevudine has the molecular formula C10H13FN2O5 and a molecular weight of 260.22 g/mol.

Sources

• DrugCentral drug card 4394 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL458875 — compound record and bioactivity
• PubChem CID 73115 — chemical identifiers
• DrugBank DB06683 — drug record
• FDA UNII IN51MVP5F1 — substance identity

How this page is built: methodology · editorial policy & corrections.